Publication | Open Access

Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan

ImmunologyCell Replacement TherapySurgeryMalignant MelanomaImmunotherapyHigh-dose MelphalanBone Marrow FailureOncologyStem Cell TransplantationHematologyCell TransplantationRadiation OncologyHealth SciencesTransplantationMarrow TransplantationMelanomaMarrow AutotransplantationMalignant Blood DisorderMedicine